Pang, H.Y.,
Chen, X.L.,
Song, X.H.,
Galiullin, D.,
Zhao, L.Y.,
Liu, K,
Zhang, W.H.,
Yang, K,
Chen, X.Z.,
Hu, J.K. (2021) (ICGFA) to prevent anastomotic leakage (AL) in rectal
cancer surgery remains controversial. Methods
Mingazheva, E.T.,
Prokofyeva, D.S.,
Valova, Ya.V.,
Andreeva, E.A.,
Nurgalieva, A.Kh.,
Valiev, R.R.,
Ekomasova, N.V.,
Faishanova, R.R.,
Romanova, A.R.,
Khusnutdinova, E.K. (2022) The high risk of ovarian
cancer is primarily associated with mutations in BRCA1 and BRCA2 genes
Fedorova, Yu. Yu.,
Aminova, E.T.,
Faishanova, R.R.,
Zagitov, I.R.,
Romanova, A.R.,
Nurgalieva, A.Kh.,
Andreeva, E.A.,
Darvish, M.,
Khusnutdinova, E.K.,
Prokofyeva, D.S. (2025) Ovarian
cancer remains one of the most common causes of death from gynecological
cancer in women
D’yakonov, V.A.,
Dzhemileva, L.U.,
Tuktarova, R.A.,
Ishmukhametova, S.R.,
Yunusbaeva, M.M.,
Ramazanov, I.R.,
Dzhemilev, U.M. (2017) , Jurkat, K562
cancer cell lines and human topoisomerase I (hTop1) inhibitory activity in vitro were found
Fedorova, Yu Yu,
Sagitova, A.V.,
Mingazheva, E.T.,
Faishanova, R.R.,
Zagitov, I.R.,
Andreeva, E.A.,
Nurgalieva, A.Kh.,
Khusnutdinova, E.K.,
Darvish, M.,
Prokofyeva, D.S. (2024) from patients with an established diagnosis of ovarian
cancer and various histological and clinical
and in combination with cisplatin in a human ovarian
cancer xenograft model. Cisplatin was used as a comparator